CELL AND GENE THERAPY INSIGHTS

October 2022 Issue

Volume 8 Issue 9

Cell and Gene Therapy Insights Volume 8 Issue 9
Download PDF

Featuring

Issue Spotlight: Gene therapy CMC and analytics
Vectors focus: Downstream bioprocessing 2022
Other articles
Webinars

SPOTLIGHT

Gene therapy CMC and analytics
Anindya Dasgupta
Guest Editor:
Anindya Dasgupta, Director of GMP at Expression Therapeutics

Expert Insight

Adeno-associated virus adsorption on different surfaces relevant to production of pre-clinical & clinical material

Adeno-associated virus adsorption on different surfaces relevant to production of pre-clinical & clinical material

Amanda Zhang, Sara Cook, Ayda Mayer
1 October 2022
Read

Innovator Insight

Accelerating your AAV pathway to GMP & clinic

Accelerating your AAV pathway to GMP & clinic

James J Cody
6 March 2023
Read
Transfection innovation for large-scale AAV & LV: considerations for process development through commercial manufacturing

Transfection innovation for large-scale AAV & LV: considerations for process development through commercial manufacturing

Leisha Kopp, Geddy Hamblen
9 November 2022
Read
A case study on streamlining AAV titer determination using variable pathlength technology

A case study on streamlining AAV titer determination using variable pathlength technology

Joe Ferraiolo, Yan Chen
31 October 2022
Read

FastFacts

High-throughput, automated analysis of viral vector titer and process-related impurities accelerates downstream process development of AAV-based gene therapies

High-throughput, automated analysis of viral vector titer and process-related impurities accelerates downstream process development of AAV-based gene therapies

30 September 2022
Read

Interview

Addressing the shortfalls of low reproducibility, low throughput classical analytics for AAV manufacturing

Addressing the shortfalls of low reproducibility, low throughput classical analytics for AAV manufacturing

Chris Heger
7 September 2022
Read
Glimpsing the future of AAV analytical innovation

Glimpsing the future of AAV analytical innovation

Wei Zhang
5 September 2022
Read

Vectors FOCUS

Downstream bioprocessing 2022

Innovator Insight

Addressing current challenges in lentiviral vector purification & associated analytics

Addressing current challenges in lentiviral vector purification & associated analytics

Bryan Zee, Anindya Dasgupta
16 January 2023
Read
Improved lentivirus recovery by weak anion exchange capture

Improved lentivirus recovery by weak anion exchange capture

Lisa Marx
16 December 2022
Read

Podcast

Improvement of viral vector purification using Mustang®️ Q membrane chromatography

Improvement of viral vector purification using Mustang®️ Q membrane chromatography

9 January 2023
Listen

articles

Expert Insight

Strategic partnering to enable cell therapy commercialization

Strategic partnering to enable cell therapy commercialization

2 October 2022
Read

Innovator Insight

Optimizing vector production and purification to enhance scalable AAV manufacturing

Optimizing vector production and purification to enhance scalable AAV manufacturing

J Zmuda, C Gaskin, J Molinari et al.
7 December 2022
Read

Expert Roundtable Video

Virtual Think-Tank on AAV vectors

Virtual Think-Tank on AAV vectors

31 October 2022
Watch

FastFacts

Accelerate your development & understanding of viral & non-viral drug delivery vectors: from proof of concept to drug product manufacture

Accelerate your development & understanding of viral & non-viral drug delivery vectors: from proof of concept to drug product manufacture

10 October 2022
Read
Leveraging the power of AI to design the best performing iPSC culture media

Leveraging the power of AI to design the best performing iPSC culture media

Asma Ayari
13 September 2022
Read

EBook

The Future of Cell and Gene Therapy: Experts’ Perspectives

The Future of Cell and Gene Therapy: Experts’ Perspectives

25 September 2022
Read

Poster

Strategic partnering to enable cell therapy commercialization: an ArsenalBio case study

Strategic partnering to enable cell therapy commercialization: an ArsenalBio case study

Jenessa Smith
4 November 2022
Read
Build vs buy dilemma: economics of manufacturing cell-based therapies

Build vs buy dilemma: economics of manufacturing cell-based therapies

Rupa Pike
24 September 2022
Read
Selecting the right elution buffer for mRNA purification using the POROS Oligo (dT)25 Affinity Resin

Selecting the right elution buffer for mRNA purification using the POROS Oligo (dT)25 Affinity Resin

Jenny England
18 September 2022
Read

Podcast

Tales, tips & teachable moments from applications support veterans

Tales, tips & teachable moments from applications support veterans

Chris Suarez, Catherine Siler, Austin Mogen
9 October 2022
Listen

Interview

Purification challenges & considerations with RNA & extracellular vesicles

Purification challenges & considerations with RNA & extracellular vesicles

Zoe Arnott
22 November 2022
Read

Webinars